$CME 8-K SEC Filings

Filed On	Filing
21 Oct 2026	8-K: Results of Operations and Financial Condition CHICAGO, October 21, 2026 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2026.
25 Sep 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year CME Group Inc., a Delaware corporation (the “Corporation”), does hereby certify that, at a duly convened meeting of the board of directors of the Corporation (the “Board of Directors”) on May 6, 2026, the Board of Directors duly adopted ...
09 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation CHICAGO, September 9, 2026 – CME Group, the world’s leading derivatives marketplace, today announced senior leadership appointments in its finance and legal divisions.
11 Aug 2026	8-K: Regulation FD Disclosure
22 Jul 2026	8-K: Results of Operations and Financial Condition
17 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
10 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
19 May 2026	8-K: Submission of Matters to a Vote of Security Holders
27 Apr 2026	8-K: Entry into a Material Definitive Agreement
22 Apr 2026	8-K: Results of Operations and Financial Condition
04 Feb 2026	8-K: Results of Operations and Financial Condition
02 Feb 2026	8-K: Regulation FD Disclosure
22 Oct 2025	8-K: Results of Operations and Financial Condition
11 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation
25 Jul 2025	8-K: Other Events
23 Jul 2025	8-K: Results of Operations and Financial Condition
09 May 2025	8-K: Submission of Matters to a Vote of Security Holders
25 Apr 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
23 Apr 2025	8-K: Results of Operations and Financial Condition
14 Apr 2025	8-K: Regulation FD Disclosure

Comments